Vaccines

Jay W. Lee, MD, MPH, FAAFP, discusses the CDC's latest guidelines regarding the COVID-19 vaccine and expanded recommendations for pneumococcal vaccines.

AAFP president discusses teaching newer physicians, expanding voices in medicine, and the upcoming flu season.

Physicians need to understand the reasons behind COVID-19 vaccine hesitancy so they can better address it.

Summer 2024 findings from the Annenberg Public Policy Center.

CDC leaders remind doctors they are the front line clinicians to get shots in arms for fall respiratory illness season.

National Academy of Medicine proposes a standard way to discuss ‘a widespread, poorly understood medical condition.’

HPV vaccine uptake increased almost 20% under guidance from the clinic-based program.

Primary care physicians are essential in combating the HIV epidemic by normalizing HIV testing and prescribing preventive medications. This approach not only enhances health equity and literacy among particularly underserved populations, but also expands their practice by attracting and retaining a broader patient base.

Unpacking vaccine pricing: navigating policy, economics, and public health imperatives.

Posts claim COVID-19 vaccines cause HIV

The top news stories in medicine today.

The top news stories in medicine today.

The top news stories in medicine today.

Patients who view animated shorts on social media gain real knowledge about COVID-19 vaccines.

The top news stories in medicine today.

FDA gave nod to six vaccines in 2023, including RSV for infants and older adults

The top news stories in medicine today.

The top news stories in primary care today.

Double dose against respiratory illness may be more convenient for patients.

New survey shows misinformation erodes credibility of immunizations.

President taps internal medicine physician with government experience.

Seasonal influenza kills hundreds of thousands of people every year due to a constantly changing virus and highly inefficient vaccine production. A universal flu vaccine could deal with the first problem, and mRNA technology with the second.

Approval is for use among adults 60 and older

Agency authorizes single-shot bivalent vaccinations, ends authorization for monovalent vaccines

The provision requiring various preventive coverages is being challenged in court